Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to $3.9 million.

  • Immucell's Cash & Current Investments rose 203.66% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 203.66%. This contributed to the annual value of $3.8 million for FY2024, which is 28398.64% up from last year.
  • According to the latest figures from Q3 2025, Immucell's Cash & Current Investments is $3.9 million, which was up 203.66% from $6.0 million recorded in Q2 2025.
  • Immucell's Cash & Current Investments' 5-year high stood at $11.8 million during Q1 2022, with a 5-year trough of $960347.0 in Q1 2024.
  • Moreover, its 5-year median value for Cash & Current Investments was $4.6 million (2025), whereas its average is $5.7 million.
  • As far as peak fluctuations go, Immucell's Cash & Current Investments tumbled by 8683.07% in 2023, and later soared by 37892.8% in 2025.
  • Over the past 5 years, Immucell's Cash & Current Investments (Quarter) stood at $10.2 million in 2021, then tumbled by 43.14% to $5.8 million in 2022, then crashed by 83.1% to $978741.0 in 2023, then surged by 283.99% to $3.8 million in 2024, then increased by 3.4% to $3.9 million in 2025.
  • Its Cash & Current Investments was $3.9 million in Q3 2025, compared to $6.0 million in Q2 2025 and $4.6 million in Q1 2025.